Product
Gepotidacin
6 clinical trials
5 indications
Indication
GonorrheaIndication
Urinary Tract InfectionsIndication
Healthy Control ParticipantsIndication
InfectionIndication
BacteriaClinical trial
A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria GonorrhoeaeStatus: Completed, Estimated PCD: 2023-10-10
Clinical trial
A Phase III, Multicenter, Randomized, Active Reference, Double Blind, Double-dummy Study in Japanese Female Participants to Evaluate the Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)Status: Recruiting, Estimated PCD: 2023-09-11
Clinical trial
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)Status: Completed, Estimated PCD: 2022-11-30
Clinical trial
A Randomized, Open-Label, Single-Dose, 2-Period, Crossover Study to Compare Gepotidacin Powder for Oral Suspension With the Adult Tablet Formulation in Healthy Male and Female Participants Aged 18 to 50 YearsStatus: Completed, Estimated PCD: 2022-04-22
Clinical trial
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)Status: Completed, Estimated PCD: 2022-12-01
Clinical trial
Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue.Status: Completed, Estimated PCD: 2023-05-27